AKAM vs CVS · P/E 27, rev $2.17B vs P/E 16, rev $106.10B
Akamai Technologies Inc (AKAM) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the AKAM and CVS stock pages for the full models.
Not investment advice.